The Millennial Majority: What Pharma Must Prepare for as the Next Generation of Doctors Reshapes Engagement in Australia

Australian medicine is entering a generational transition, with millennials set to become the largest cohort as baby boomer and Generation X doctors retire over the next decade.

This is a challenge because trust in pharmaceutical companies is particularly low among younger clinicians. In the AusDoc BIG Doctor Survey (2025), millennial doctors gave pharma a net promoter score of –79.9, with more than 80% classified as detractors.

Trust issues aside, millennial doctors remain engaged with pharma content, but on their terms. Attitudinal research shows younger clinicians readily engage with pharma content via aggregated clinical platforms, guidelines and independent medical publications, favouring concise, evidence-led information delivered within their clinical workflow or digital ecosystem.

For pharma companies, the opportunity is to engage doctors in the channels they trust with audience-first, digestible and trustworthy information that helps them make faster, evidence-based decisions for their patients.

This whitepaper draws on recent research to help pharma marketers, sales and medical teams future-proof their engagement with the next generation of clinicians over the next five to ten years.